Evidence for Marfan cardiomyopathy

Marfan syndrome (MFS) is an inherited connective tissue disease which frequently involves the cardiovascular system. The heart can be affected since valvular regurgitation is a common complication. However, there is still debate whether a primary cardiomyopathy exists. Our aim was to evaluate the existence of a Marfan‐related cardiomyopathy using cardiovascular magnetic resonance.

[1]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[2]  J. Camm,et al.  Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome. , 2009, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[3]  R. Vracko,et al.  Spatial arrangements of microfibrils in myocardial scars: application of antibody to fibrillin. , 1990, Journal of molecular and cellular cardiology.

[4]  P. Hekali,et al.  Left ventricular function in children with the Marfan syndrome. , 1994, European heart journal.

[5]  Gervasio A. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[6]  Jennifer Keegan,et al.  Aortic Root Measurement by Cardiovascular Magnetic Resonance: Specification of Planes and Lines of Measurement and Corresponding Normal Values , 2008, Circulation. Cardiovascular imaging.

[7]  James C Moon,et al.  Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. , 2004, American heart journal.

[8]  Dudley J Pennell,et al.  Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. , 2002, The American journal of cardiology.

[9]  R. Devereux,et al.  Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome. , 1989, The American journal of cardiology.

[10]  J. Stockman,et al.  Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome , 2010 .

[11]  J. Timmermans,et al.  Evaluation of left ventricular dimensions and function in Marfan's syndrome without significant valvular regurgitation. , 2005, The American journal of cardiology.

[12]  H. Dietz,et al.  Marfan syndrome: from molecular pathogenesis to clinical treatment. , 2007, Current opinion in genetics & development.

[13]  B. Das,et al.  Left Ventricular Diastolic Dysfunction in Children and Young Adults with Marfan Syndrome , 2006, Pediatric Cardiology.

[14]  N. Rofsky,et al.  Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[15]  Dudley J Pennell,et al.  Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. , 2006, European heart journal.

[16]  D. Pennell,et al.  Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[17]  Patrick Segers,et al.  Primary impairment of left ventricular function in Marfan syndrome. , 2006, International journal of cardiology.

[18]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[19]  V. McKusick,et al.  The Marfan syndrome: diagnosis and management. , 1979, The New England journal of medicine.

[20]  Masashi Takahashi,et al.  Myocardial involvement in the Marfan syndrome. , 1985, Japanese heart journal.

[21]  R. Devereux,et al.  Family history of severe cardiovascular disease in Marfan syndrome is associated with increased aortic diameter and decreased survival. , 1995, Journal of the American College of Cardiology.

[22]  D. Driscoll,et al.  Left ventricular function in the Marfan syndrome without significant valvular regurgitation. , 2003, American Journal of Cardiology.

[23]  Lippincott Williams Wilkins,et al.  ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .

[24]  Raad Mohiaddin,et al.  How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[25]  L. Zanolla,et al.  Reduced right ventricular ejection fraction as a marker for idiopathic dilated cardiomyopathy compared with ischemic left ventricular dysfunction. , 2001, American heart journal.

[26]  John Camm,et al.  Early impairment of left ventricular long-axis systolic function demonstrated by reduced atrioventricular plane displacement in patients with Marfan syndrome. , 2008, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[27]  K. Nath,et al.  Marfan's syndrome. , 1959, Journal of the Indian Medical Association.

[28]  Olaf Franzen,et al.  Tissue Doppler imaging identifies myocardial dysfunction in adults with marfan syndrome , 2007, Clinical cardiology.